Clinico-hematological profile and thrombotic/hemorrhagic events in 150 chinese patients with essential thrombocythemia

Essential thrombocythemia (ET) is one of the myeloproliferative neoplasms characterized by abnormal bone marrow megakaryocyte proliferation, elevated platelet count and a tendency to develop vascular complications, including thrombosis and hemorrhage. Age, WBC count and thrombotic history have been confirmed as independent risk factors for future thrombotic events in previous studies. One of these studies also identified cardiovascular (CV) risk factors and JAK2 V617F mutation as prognostic marker for future thrombosis when adhering to the recent International Prognostic Score for Thrombosis in ET (IPSET-thrombosis) [1].
Source: Leukemia Research - Category: Hematology Authors: Tags: Research paper Source Type: research